Literature DB >> 28254463

Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease.

Paolo Gionchetti1, Fernando Rizzello2, Vito Annese3, Alessandro Armuzzi4, Livia Biancone5, Fabiana Castiglione6, Michele Comberlato7, Mario Cottone8, Silvio Danese9, Marco Daperno10, Renata D'Incà11, Walter Fries12, Anna Kohn13, Ambrogio Orlando8, Claudio Papi14, Maurizio Vecchi15, Sandro Ardizzone16.   

Abstract

The two main forms of intestinal bowel disease, namely ulcerative colitis and Crohn's disease, are not curable but can be controlled by various medical therapies. The Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) has prepared clinical practice guidelines to help physicians prescribe corticosteroids and immunosuppressive drugs for these patients. The guidelines consider therapies that induce remission in patients with active disease as well as treatment regimens that maintain remission. These guidelines complement already existing guidelines from IG-IBD on the use of biological drugs in patients with inflammatory bowel diseases.
Copyright © 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Corticosteroids; Crohn's disease; Guidelines; IBD; Immunosuppressors; Ulcerative colitis

Mesh:

Substances:

Year:  2017        PMID: 28254463     DOI: 10.1016/j.dld.2017.01.161

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  16 in total

1.  Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy.

Authors:  Giuseppe Leoncini; Vincenzo Villanacci; Maria Grazia Marin; Valentina Crisafulli; Moris Cadei; Elisabetta Antonelli; Claudio Leoci; Gabrio Bassotti
Journal:  Tech Coloproctol       Date:  2018-12-10       Impact factor: 3.781

2.  Serious and Opportunistic Infections in Elderly Patients With Inflammatory Bowel Disease.

Authors:  Elissa Lin; Kevin Lin; Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-11

3.  Effect of Aqueous Extract of Phenolic Compounds Obtained from Red Wine in Experimental Model of Colitis in Mice.

Authors:  Vanessa Mateus; João Estarreja; Inês Silva; Fernando Gonçalves; Edite Teixeira-Lemos; Rui Pinto
Journal:  Curr Issues Mol Biol       Date:  2022-06-18       Impact factor: 2.976

4.  Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study.

Authors:  Fabio Salvatore Macaluso; Walter Fries; Sara Renna; Anna Viola; Marco Muscianisi; Maria Cappello; Laura Guida; Sebastiano Siringo; Salvatore Camilleri; Serena Garufi; Antonino Carlo Privitera; Nunzio Belluardo; Emiliano Giangreco; Carmelo Bertolami; Roberto Vassallo; Giulia Rizzuto; Rosalba Orlando; Marco Ventimiglia; Ambrogio Orlando
Journal:  United European Gastroenterol J       Date:  2020-08-09       Impact factor: 4.623

5.  TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.

Authors:  Bo Xiao; Qiubing Chen; Zhan Zhang; Lixin Wang; Yuejun Kang; Timothy Denning; Didier Merlin
Journal:  J Control Release       Date:  2018-08-11       Impact factor: 9.776

6.  Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis.

Authors:  Lauren Sahakian; Rhiannon T Filippone; Rhian Stavely; Ainsley M Robinson; Xu Sean Yan; Raquel Abalo; Rajaraman Eri; Joel C Bornstein; Mark R Kelley; Kulmira Nurgali
Journal:  Inflamm Bowel Dis       Date:  2021-02-16       Impact factor: 5.325

7.  Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study.

Authors:  Stefano Festa; Maria L Scribano; Daniela Pugliese; Cristina Bezzio; Mariabeatrice Principi; Davide G Ribaldone; Mariangela Allocca; Giammarco Mocci; Giorgia Bodini; Rocco Spagnuolo; Piero Vernia; Silvia Mazzuoli; Francesco Costa; Brigida Barberio; Rocco Cosintino; Giulia Zerboni; Annalisa Aratari; Alessandro Armuzzi; Claudio Papi
Journal:  United European Gastroenterol J       Date:  2021-02-16       Impact factor: 4.623

8.  Effects of indigo naturalis on colonic mucosal injuries and inflammation in rats with dextran sodium sulphate-induced ulcerative colitis.

Authors:  Yunliang Wang; Lijuan Liu; Yi Guo; Tangyou Mao; Rui Shi; Junxiang Li
Journal:  Exp Ther Med       Date:  2017-06-28       Impact factor: 2.447

9.  Serology of Viral Infections and Tuberculosis Screening in an IBD Population Referred to a Tertiary Centre of Southern Italy.

Authors:  Marco Ardesia; Giuseppe Costantino; Placido Mondello; Angela Alibrandi; Walter Fries
Journal:  Gastroenterol Res Pract       Date:  2017-09-17       Impact factor: 2.260

10.  Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study.

Authors:  Daniela Pugliese; Giuseppe Privitera; Francesca Rogai; Angela Variola; Anna Viola; Lucrezia Laterza; Antonino C Privitera; Mariangela Allocca; Fabrizio Bossa; Maria Cappello; Marco Daperno; Greta Lorenzon; Silvia Mazzuoli; Mariabeatrice Principi; Renato Sablich; Luisa Moser; Antonio Ferronato; Sara Traini; Gherardo Tapete; Giorgia Bodini; Maria Di Girolamo; Laurino Grossi; Giammarco Mocci; Chiara Ricci; Simone Saibeni; Stefano Festa; Rocco Spagnuolo; Claudio C Cortelezzi; Filippo Mocciaro; Fernando Rizzello; Alessandro Armuzzi
Journal:  United European Gastroenterol J       Date:  2021-03-01       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.